Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BAL PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 BAL PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    BAL PHARMA
Mar-23
TEVA PHARMA
Dec-13
BAL PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1343,479-   
Low Rs633,022-   
Sales per share (Unadj.) Rs193.91,996.4-  
Earnings per share (Unadj.) Rs1.7124.7-  
Cash flow per share (Unadj.) Rs7.5286.1-  
Dividends per share (Unadj.) Rs1.00109.18-  
Avg Dividend yield %1.03.4 30.1%  
Book value per share (Unadj.) Rs40.72,217.6-  
Shares outstanding (eoy) m15.69848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.51.6 31.3%   
Avg P/E ratio x59.226.1 227.0%  
P/CF ratio (eoy) x13.211.4 116.1%  
Price / Book Value ratio x2.41.5 165.7%  
Dividend payout %59.987.5 68.4%   
Avg Mkt Cap Rs m1,5492,756,220 0.1%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m5530-   
Avg. sales/employee Rs Th037,667.6-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,353.1-  
INCOME DATA
Net Sales Rs m3,0421,692,969 0.2%  
Other income Rs m90-   
Total revenues Rs m3,0521,692,969 0.2%   
Gross profit Rs m253463,620 0.1%  
Depreciation Rs m91136,844 0.1%   
Interest Rs m12333,253 0.4%   
Profit before tax Rs m47293,523 0.0%   
Minority Interest Rs m01,333 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,682 -0.0%   
Tax Rs m21-3,584 -0.6%   
Profit after tax Rs m26105,758 0.0%  
Gross profit margin %8.327.4 30.3%  
Effective tax rate %44.8-1.2 -3,672.4%   
Net profit margin %0.96.2 13.8%  
BALANCE SHEET DATA
Current assets Rs m2,2821,143,425 0.2%   
Current liabilities Rs m2,093997,163 0.2%   
Net working cap to sales %6.28.6 71.6%  
Current ratio x1.11.1 95.0%  
Inventory Days Days891 8.4%  
Debtors Days Days1,12896 1,175.6%  
Net fixed assets Rs m829552,961 0.1%   
Share capital Rs m1574,167 3.8%   
"Free" reserves Rs m4810-   
Net worth Rs m6381,880,567 0.0%   
Long term debt Rs m305865,653 0.0%   
Total assets Rs m3,1103,868,976 0.1%  
Interest coverage x1.49.8 14.1%   
Debt to equity ratio x0.50.5 104.0%  
Sales to assets ratio x1.00.4 223.5%   
Return on assets %4.83.6 133.6%  
Return on equity %4.15.6 73.0%  
Return on capital %18.14.9 366.9%  
Exports to sales %66.40-   
Imports to sales %22.40-   
Net fx Rs m1,3050-   
CASH FLOW
From Operations Rs m-18269,772 -0.0%  
From Investments Rs m-222-95,591 0.2%  
From Financial Activity Rs m244-323,609 -0.1%  
Net Cashflow Rs m4-149,429 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare BAL PHARMA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare BAL PHARMA With: KABRA DRUGS  DIVIS LABORATORIES  AARTI PHARMALABS  GLENMARK PHARMA  MESCO PHARMA  



Today's Market

Sensex Today Ends 487 Points Higher | Metal Stocks Shine | SBI & Axis Bank Zoom 5% Sensex Today Ends 487 Points Higher | Metal Stocks Shine | SBI & Axis Bank Zoom 5%(Closing)

After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.